Advertisement
Screener

Aura Biosciences, Inc. (AURA) Form D

Aura Biosciences, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2021-04-06: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2021-03-18; Total offering amount $80,483,829.
  • 2020-07-09: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2020-06-25; Total offering amount $17,000,010.
  • 2019-04-12: Federal exemption Rule 506(b); Types of securities offered Equity; Date of first sale 2019-04-01; Total offering amount $40,000,000.
  • 2014-08-14: Federal exemption Rule 506(c); Types of securities offered Equity; Date of first sale 2014-04-15; Total offering amount $4,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2021-04-06Rule 506(b)Equity2021-03-18$80,483,829$80,483,829$041
2020-07-09Rule 506(b)Equity2020-06-25$17,000,010$10,000,016$6,999,99432
2019-04-12Rule 506(b)Equity2019-04-01$40,000,000$20,000,000$20,000,00036
2014-08-14Rule 506(c)Equity2014-04-15$4,000,000$4,000,000$041
2012-12-26Rule 506Equity2012-08-31$3,226,728$3,226,728$022
2011-08-26Rule 506Equity2011-05-10$2,925,000$2,925,000$023

Similar stocks

Stock NameCountryMarket CapPE Ratio
Allogene Therapeutics, Inc. (ALLO)United States$0.574B-4.33
Prime Medicine, Inc. (PRME)United States$0.557B-3.54
4D Molecular Therapeutics, Inc. (FDMT)United States$0.733B-4.10
Autolus Therapeutics plc (AUTL)$0.506B-1.52
Entera Bio Ltd. (ENTX)$0.485B
REGENXBIO Inc. (RGNX)United States$0.477B-3.30
Solid Biosciences Inc. (SLDB)United States$0.802B-5.07
Tectonic Therapeutic, Inc. (TECX)United States$0.469B-7.68
Attovia Therapeutics, Inc. (ATTO)United States$0.828B
Eikon Therapeutics, Inc. (EIKN)United States$0.446B